$306.80

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku CI27624_1_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
2'-Deoxy-5-azacytidine
Brand Name
Chem Impex
Product Number
27624
CAS
2353-33-5
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
451668
IUPAC Name
4-amino-1-(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl-1,3,5-triazin-2-one
InChI Key
XAUDJQYHKZQPEU-KVQBGUIXSA-N
SMILES
C1C@@H(C@H(OC@H1N2C=NC(=NC2=O)N)CO)O

Application

2'-Deoxy-5-azacytidine is widely utilized in research focused on:

Cancer Treatment: This compound is being explored as a potential therapeutic agent in oncology. It has shown promise in inhibiting tumor growth by affecting DNA methylation, which is crucial in cancer progression.

Epigenetic Research: Researchers use it to study epigenetic modifications. Its ability to mimic cytidine allows scientists to investigate the role of DNA methylation in gene expression and cellular differentiation.

Antiviral Applications: The compound is being investigated for its antiviral properties, particularly against certain viruses. Its mechanism can interfere with viral replication, making it a candidate for developing antiviral therapies.

Cellular Reprogramming: In stem cell research, it is used to enhance the reprogramming efficiency of somatic cells into induced pluripotent stem cells (iPSCs), which is vital for regenerative medicine.

Drug Development: Pharmaceutical companies are exploring its potential as a lead compound for developing new drugs targeting various diseases, leveraging its unique chemical structure for improved efficacy.

References

[Yeasts in the lung-colonization or catastrophe? : An infectious disease complication in a patient with acute myeloid leukemia]

Publication Name: Medizinische Klinik, Intensivmedizin und Notfallmedizin
Publication Date: 2026-04
DOI: 10.1007/s00063-025-01301-9

TOLLIP targets GSDME-NT-carrying endocytic vesicles for autophagy to regulate pyroptosis and chemotherapy efficacy

Publication Name: Nature Cell Biology
Publication Date: 2026-03-09
DOI: 10.1038/s41556-026-01902-2

Computer-aided drug design in acute myeloid leukemia: a comprehensive review of advances, challenges, and future prospect

Publication Name: Journal of Computer-Aided Molecular Design
Publication Date: 2026-03-03
DOI: 10.1007/s10822-026-00771-z

CAR T cells derived from a novel, high-affinity anti-CLL-1 monoclonal antibody exhibit a significant anti-AML effect

Publication Name: Cancer immunology, immunotherapy : CII
Publication Date: 2026-03-02
DOI: 10.1007/s00262-026-04342-x